Upregulated E26 Transformation-Specific Variant Transcription Factor 7 in Oral Squamous Cell Carcinoma: Clinicopathological Correlations and Immune Regulatory Mechanisms
ETV7 upregulation drives OSCC progression, potentially through immune microenvironment modulation, positioning it as a candidate biomarker and therapeutic target. Its association with clinical stage and immunotherapy response underscores its prognostic relevance in OSCC management.
Authors
- Xiangzhi Yong (ORCID: https://orcid.org/0000-0002-0208-9171)
- Charlene Yu Lin Tang (ORCID: https://orcid.org/0000-0001-6051-7077)
- Rong‐Rong He (ORCID: https://orcid.org/0000-0001-5505-5672)
- Gang Chen (ORCID: https://orcid.org/0000-0003-2402-2987)
- Ping Li (ORCID: https://orcid.org/0000-0002-8775-5523)
- Jian Di Li
- Rongpin Tao
Institutions
- Guangxi Medical University (CN)
- First Affiliated Hospital of GuangXi Medical University (CN)
- Guangxi Center for Disease Prevention and Control (CN)
Publication Details
- Journal
- World Journal of Oncology
- Published
- 2025-07-26
- DOI
- https://doi.org/10.14740/wjon2606
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00